Back
Canaan Vs. Kymera Therapeutics Industry Stock Comparison
Buy
59
CAN
Canaan
Last Price:
$0.80
Seasonality Move:
-7.84%
Buy
77
KYMR
Kymera Therapeutics
Last Price:
$45.02
Seasonality Move:
-8.02%
Buy
77
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $45.79. The Score for KYMR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CAN Stock Price Chart
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $45.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
CAN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 51.58 | Buy |
Chaikin Money Flow: | -14700602 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.62 - 0.86) | Buy |
Bollinger Bands (100): | (0.62 - 0.96) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.65 | Buy |
Relative Strength Index (14 RSI): | 56.87 | Buy |
Chaikin Money Flow: | 15209 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.33 - 46.23) | Buy |
Bollinger Bands (100): | (27.72 - 44.14) | Buy |
CAN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.87 | Sell |
20-day SMA: | 0.78 | Buy |
50-day SMA: | 0.71 | Buy |
200-day SMA: | 1.28 | Sell |
8-day EMA: | 0.84 | Sell |
20-day EMA: | 0.8 | Buy |
50-day EMA: | 0.77 | Buy |
200-day EMA: | 1.09 | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.88 | Sell |
20-day SMA: | 45.02 | Buy |
50-day SMA: | 41.89 | Buy |
200-day SMA: | 39.32 | Buy |
8-day EMA: | 10.18 | Buy |
20-day EMA: | 4.36 | Buy |
50-day EMA: | 1.8 | Buy |
200-day EMA: | 0.46 | Buy |
Canaan Earnings Growth & CAN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.22 per share, an increase this year of $0.08 per share, and an increase next year of $0.43 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.65 per share, and a decrease next year of $0.51 per share.
Canaan Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |